Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Survival in Systemic Sclerosis with Pulmonary Arterial Hypertension Has Not Improved in the Modern Era.

PAH

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 11 August 2013 - 10:08 PM

Survival in Systemic Sclerosis with Pulmonary Arterial Hypertension Has Not Improved in the Modern Era.

 

Despite an improvement in clinical status, unlike patients with pulmonary arterial hypertension, the mortality in systemic sclerosis has not improved since the introduction of epoprostenol. CHEST Journal, June 6 2013. (Also see: Pulmonary Hypertension Prognosis and Flolan/Prostacyclin/Epoprostenol)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: PAH